HeartSciences Inc.
HSCS
$3.03
$0.217.45%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 71.45% | 3.22% | 19.20% | 30.45% | -3.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.57% | -9.62% | 2.39% | 53.98% | 26.13% |
| Operating Income | -4.45% | 9.71% | -2.16% | -55.47% | -26.44% |
| Income Before Tax | -12.86% | -0.16% | -13.44% | -54.29% | -19.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.86% | -0.16% | -13.44% | -54.29% | -19.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.86% | -0.16% | -13.44% | -54.29% | -19.13% |
| EBIT | -4.45% | 9.71% | -2.16% | -55.47% | -26.44% |
| EBITDA | -4.74% | 9.54% | -2.26% | -55.45% | -26.28% |
| EPS Basic | 62.76% | 40.24% | 30.86% | 14.46% | 85.74% |
| Normalized Basic EPS | 62.76% | 40.24% | 30.87% | 14.46% | 85.74% |
| EPS Diluted | 62.76% | 40.24% | 30.86% | 14.46% | 85.74% |
| Normalized Diluted EPS | 62.76% | 40.24% | 30.87% | 14.46% | 85.74% |
| Average Basic Shares Outstanding | 203.08% | 67.61% | 64.10% | 80.37% | 735.52% |
| Average Diluted Shares Outstanding | 203.08% | 67.61% | 64.10% | 80.37% | 735.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |